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Abstract 
Background: Drug-related problems are known to be a major problem associated with pharmacotherapy. A broad range of studies, 
mainly in the area of prescription-only medicines, supports this fact. Only a few studies have evaluated drug-related problems with 
over-the-counter medicine and the role of community pharmacies in this. 
Purpose: To quantify drug-related problems in self-medication (use of over-the-counter medicine) identified by community 
pharmacies in Denmark and to document the interventions by pharmacy staff in relation to the identified drug-related problems. 
Method: A descriptive study mapping drug-related problems in self-medication registered at the counter at a selected number of 
Danish community pharmacies. 
Results: Data for 3,868 consecutive customers with requests for over-the-counter (OTC) medicines were registered at 39 community 
pharmacies. The pharmacies registered a total number of 4,324 OTC medicines requests, illustrating that a customer requested 1.1 
OTC medicines on average. Drug-related problems (DRPs) were identified for 813 customers, equivalent to DRPs for 21.0 % of all 
customers, presenting symptoms or requesting OTC medicines, and for 20 % of all over-the-counter medicines requests. 1,239 DRPs 
were registered, corresponding to an average of 1.5 DRPs per customer requesting OTC medicines. 
Community pharmacies estimated that they solved or partly solved 76.2 % of the detected DRPs; 73 % were solved without involving 
a general practitioner. 
Conclusions: DRPs were identified for 21.0 % of the pharmacy customers presenting a symptom or asking for an OTC medicine. The 
community pharmacy counselled the customers with DRPs more thoroughly than other customers by giving 2.4 pieces of professional 
advice, compared to an average of 2.1 to customers in general. It is not possible to determine the magnitude of the safety risk 
involved. Based on the most frequent categories of DRPs, there were risks of insufficient effect, unintended effects and, to a lesser 
extent, inappropriate self-medication. 
 
 
Introduction 
Drug-related problems (DRPs) are known to be a major 
problem associated with pharmacotherapy
2-4. A broad range 
of studies, mainly in the area of prescription-only medicines, 
supports this fact
5-9. A DRP has been defined by Hepler and 
Strand as: “A drug-related problem is an event or 
circumstance involving drug treatment that actually or 
potentially interferes with the patient's experiencing an 
optimum outcome of medical care”. There are few Danish  
studies on DRPs: Danish pharmaceutical care research 
projects documented DRPs for asthma patients and for the 
elderly, and later, a Danish study documented DRPs in 
general practice
10-12. Elderly citizens living in nursing homes 
have been in focus in several Danish research projects, 
concentrating on ensuring an effective handling of DRPs
13-15. 
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Only a few studies have evaluated DRPs with OTC medicines 
and the role of community pharmacies in preventing or 
resolving these problems
16-20.  
 
Denmark has a population of 5.4 million people, who are 
served by 314 pharmacies, corresponding to 17,200 
inhabitants per pharmacy. A pharmacy is obliged to provide 
all pharmacy-restricted medicines, regardless of whether they 
are on prescription or not. In practice, this means that the 
pharmacy must have any medicine requested in stock or be 
able to deliver it within 24 hours. Since October 2001, other 
outlets like supermarkets and kiosks have been permitted to 
sell a selection of OTC medicines
1. 
 
In Denmark, community pharmacies are the primary source 
of OTC medicines
1. OTC medicines at the pharmacy are only 
available on request at the counter, and not via self-service. 
Apart from the medicines supply, Danish community 
pharmacies are responsible for providing information and 
counselling to ensure a safe drug use. Pharmacies also 
provide pharmaceutical care and preventive services, Original Research  PHARMACY PRACTICE 
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contributing to health promotion, ill-health prevention, self-
care, and the appropriate use of drugs. Community 
pharmacies keep information on prescription medicines for 
their customers, but not on OTC medicines. 
 
Over the last decade, there has been a development in 
Denmark towards deregulation making the access to OTC 
medicines easier for the public
1. Starting in October 2001, 
other outlets (e.g. supermarkets and kiosks) have been 
permitted to sell a selection of OTC medicines. The total 
consumption of OTC medicines did not change despite the 
increased number of outlets. The pharmacies’ share (in DDD) 
of the OTC medicines was 83 % in 2010
21. 
 
However, when buying OTC medicines from other outlets 
than pharmacies, the only information and counselling 
customers get is the information written on the package, as 
unskilled staff are not allowed to give information on 
medicines. This underlines the importance of pharmacy staff 
giving professional advice to OTC customers.  
 
A British article raised the awareness to safety issues of OTC 
medicines saying that the public needs to be aware that OTC 
medicines should be treated with the same care as prescribed 
medicines, and that advice on recommended dose, 
contraindications and interactions should be adhered to
22. 
 
Several examples of studies of counselling on OTC 
medicines
23;18;24 were made in Sweden:  
One study concluded that a counselling model designed to 
discover and resolve problems related to symptoms and drug 
use appeared to have a favourable impact on outcomes in 
customers with dyspepsia seeking non-prescription drug 
treatment in Swedish pharmacies
23. A parallel Danish 
intervention study showed similar results for dyspepsia and 
hay-fever customers
16. Another Swedish study demonstrated 
a need for more professional attention and intervention by 
pharmacy staff to prevent and rectify DRPs for non-
prescription consumers. It was particularly important to make 
sure that consumers receive the appropriate drugs for their 
current ailments
18. It was also found that counselling was a 
means to improve drug use, when it came to prescription-
only medicines. More DRPs were found in patients sending a 
representative to pick up their medicines than in patients 
visiting the pharmacy themselves
25. 
 
In a German study with 11,069 pharmacy customers, a direct 
pharmacist-patient interaction about self-medication 
revealed relevant DRPs in nearly 1 out of 5 encounters. 
Approximately 75 % of the customers requested a specific 
OTC medicine. In these cases, the majority of DRPs was 
identified (80 %). The most frequent DRPs were: 
inappropriate self-medication, inappropriate requested drug, 
too long duration of drug use (including abuse), and wrong 
dosage
17. 
 
The frequency and distribution of DRPs among Danish 
pharmacy customers is unknown. Hence  this project was 
inspired by the  German study, which described the nature 
and frequency of DRPs in self-medication (OTC drugs) in daily 
community pharmacy practice in Germany
17. In order to allow 
for comparison of results, a similar method with similar 
documentation forms was used. 
 
Purpose 
The purpose of the study was: 
  to provide a quantitative description of the nature and 
frequency of drug-related problems in self-medication as 
identified by community pharmacies in Denmark 
  to document the interventions by pharmacy staff in 
relation to the identified drug related problems 
 
Method 
The project was designed as a descriptive study performed at 
a convenience sample of Danish community pharmacies, 
mapping DRPs registered at the pharmacy counter when 
selling OTC medicines. 
 
At each pharmacy two staff members (at least one 
pharmacist, and possibly a pharmaconomist
1) were trained in 
the registration process in order to ensure a consistent 
documentation. The training was based on the registration of 
five test cases, followed up by a problem-solving conference 
call (four pharmacies at a time with two researchers). 
Following the training period, the pharmacists were 
instructed to register 100 consecutive customers with an OTC 
request per pharmacy. 
 
The registration was electronic, using a link to the Intranet, a 
programme available at all pharmacies. 
 
Setting and study population 
The study was conducted in June and July 2011 in Danish 
community pharmacies. Pharmacies were invited to join the 
project via an announcement on the website of the 
Association of Danish Pharmacies in April 2011. Participation 
was optional. However, as this did not provide a sufficient 
number of pharmacies, a telephone follow-up was initiated. 
Each participating pharmacy provided two employees (at 
least one pharmacist and possibly a pharmaconomist). 
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The participation of pharmacies was financially compensated 
to the participating pharmacies by the Association of Danish 
Pharmacies (with 3,000 DKK, corresponding to approx. 400 
EUR). The compensation was given after data had been 
received at Pharmakon. 
 
The pharmacies were instructed each to register 100 
consecutive customers, a strategy used to avoid bias in the 
selection of customers. A customer would be included when 
asking for an OTC-medicine or presenting a symptom or a 
problem. Data was registered immediately after the dialogue 
with the customer. 
 
The staff members were trained in identifying and 
documenting DRPs, based on the quality standard applying 
for counselling at the counter, and in electronic registration 
of data. The standard follows The Danish Healthcare Quality 
Programme
27. The project had a website, available via a link 
to the Intranet, and a programme available at all pharmacies 
for the distribution of documents and for the registration of 
data. Videos demonstrating advice-giving at the counter and 
the registration of data were available at the same website as 
well as five cases intended for training to make 
implementation of the process uniform in all pharmacies. The 
participating pharmacists and pharmaconomists prepared 
themselves by working on these cases. Following the training 
period, a series of conference calls were organized, each with 
ten participants, including two researchers from Pharmakon 
as moderators. Extracts from the conference calls were 
distributed to the participants afterwards. 
 
Data collection and analysis 
An electronic registration form was developed for the project, 
using the same SharePoint platform as used for the 
pharmacies’ intranet sites. 
 
The registration form was inspired by the German 
registration form
17. Documentation included data on patient 
characteristics (e.g. estimated age, gender, availability of a 
patient file including drug history in the pharmacy), and the 
nature of the OTC request (e.g. symptom presentation, OTC 
medicine request, first-time or repeat request, indication). If 
one or more DRPs were detected, the nature and solution of 
each DRP were recorded; the most frequent DRPs, 
interventions, and problem solutions were provided as check 
boxes on the form. Pharmacists were requested to document 
other DRPs, interventions, and solutions not provided as 
check boxes in free-text fields. Furthermore, the time needed 
for solving the problem was recorded. In the development 
phase, contact was taken to the German researchers as well 
as to the Association of Danish Pharmacies concerning the 
phrasing of some of the questions in order to ensure high 
validity. This was in particular applicable with respect to the 
categories of symptoms, the DRPs and the interventions by 
the pharmacy staff. The registration form was tested in the 
training phase, and minor corrections were made. Only 
customers requesting OTC medicines or presenting symptoms 
for themselves or for their children (under the age 15) were 
included in the study.  
 
Registrations were made on the basis of each OTC request. 
Up to three OTC requests could be registered for one single 
customer. Data were transferred from the registration form 
to an Excel file and later on to SPSS (Version 19). A random 
quality check was performed on the registrations. Data were 
analyzed in SPSS as crosstabs and frequencies. No statistical 
tests were performed. 
 
Results 
Data were collected from 39 community pharmacies (out of a 
total of 314 community pharmacies, corresponding to 12.5 
%
28). They documented data from 3,868 customers with a 
total of 4,324 OTC requests, corresponding to each customer 
having 1.1 OTC requests. See details in Table 1. 
 
Gender and age 
Gender and age were registered for 3,765 customers. 2,409 
(64.0 %) were female, and 1,356 (36.0 %) were male. Almost 
2/3 of all customers in the survey were between 21 and 64 
years old. More than every third customer was in the age 
group 41-64 years (35.2 %). In 10.4 % of requests, the OTC 
medicines requested were for children.  
 
OTC requests and customers’ experiences 
It was registered whether customers presented a symptom or 
requested an OTC-medicine. Customers were asked if they 
had any experience with the requested OTC-medicine, and 
whether it was a first-time request or not. It should be noted 
that the sum of requests is higher than the number of 
customers, thus explaining that the percentages of customers 
are >100 % in Table 2. 
 
The results showed that 85.1 % of the customers were 
frequent users, which meant that the customers had bought 
the medicine at least once before. They also showed that 
78.3 % asked for a specific OTC medicine, and that only a 
minor part presented a symptom (6.8 %). Slightly more than 
1/4 of the customers were first-timers with regards to the 
actual treatment (26.8 %). Half of the first-timers presented a 
symptom, and half requested an OTC- medicine (13.8 % and 
13.0 % respectively). 
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Prevalence of DRPs  
DRPs were registered for 813 customers (out of the total 
number of 3,868 customers in the survey), which corresponds 
to 21.0 % of all customers.  
The survey documented 1,239 DRPs for 813 customers, 
corresponding to an average of 1.5 problems for a customer 
with DRP, as 7.3 % of the customers had more than one DRP.  
 
The survey documented 4,324 OTC requests and 842 DRP, 
corresponding to DRP for 19.7 % of the OTC requests.   
  
Presented symptoms  
Symptoms presented, or symptoms for which the requested 
OTC-medicine was intended to treat were registered. If the 
customer had more than one OTC request, the symptom for 
each OTC request was registered. Symptoms were registered 
for 2,912 customers in the survey. 
 
Customers with DRPs had symptoms similar to customers’ 
without DRPs. Pain was by far the most frequent symptom 
and was registered with more than half of the customers in 
the survey (57.6 %). The second most frequent symptom was 
allergy or hay fever, which was registered for almost every 
fifth customer (16.7 % of all customers). Data were registered 
in June/July, a period with a relatively high pollen occurrence 
in Denmark, which influences the prevalence of symptoms. 
Pain and allergy/hay fever together were the symptoms 
presented by nearly 3/4 of all customers in the survey. 
Customers with allergy or hay fever tended to have more 
DRPs (20.3 %) than all customers in the survey (16.7 %).  
 
Types of DRPs 
Table 2 shows an overview of the types of DRPs identified in 
the study. 
 
The results showed that the most frequent DRP was: “Choice 
of self-medication is not appropriate/optimal for the 
condition”. This problem was registered 364 times and for 
almost half of the customer with DRPs. 
 
The second most frequent DRPs were documented for 10 to 
20 % of customers with a DRP: ”Too little of the drug is being 
taken”, ”The drug is taken for too long (dependency)” and 
”Adverse drug events”. 
 
Pharmacy interventions 
Pharmacy staff registered interventions (including 
counselling) in relation to each customer, presenting a DRP or 
not. More than one intervention could be registered, if 
appropriate. 
 
Figure 1 shows the pharmacy interventions. It shows a higher 
frequency of interventions for customers with DRPs. 
”Counselling on self-medication”, which according to the 
instruction covered optimal choice and use of the OTC 
medicines,  was the most frequent intervention and was 
given to almost 3/4 (73.5 %) of all customers. For customers 
with DRPs it was given to 87.5 %. 
 
”Referral to General Practitioner (GP)” (covers direct referral 
as well as conditional referral) was given more frequently to 
customers with DRPs (35.2 % versus 10.7 %). The intervention 
“Recommendation of another drug” was given to 23.0 % of 
customers with DRPs and to 6.7 % of other customers.  
 
Solving DRPs  
The pharmacy staff estimated whether the DRP was solved, 
partly solved, or not solved. 
 
Pharmacists solved or partially solved DRPs for 90.5 % (76.2 + 
14.3) of all OTC customers and for 78.0 % (45.6 + 32.4) of 
customers with DRPs. 
The results showed that 73 % of the DRPs were solved by the 
pharmacy staff without consulting the GP and that 35.2 % of 
the customers with DRPs were referred to a GP. 
 
It should be noted that pharmacy staff responded in general 
to how they had contributed to overall problem solving, no 
matter whether a DRP was identified or not.  
 
By comparing counselling and DRPs it appeared that the 
problem: ”The choice of self-medication is not appropriate”, 
the most frequent solution was ”Counselling on self-
medication”. ”Too low dosage” was solved by counselling on 
self-medication or by suggesting another drug. When a 
customer experienced side-effects, the pharmacy staff 
counselled on self-medication or referred to the general 
practitioner, possibly replacing the drug in question. In case 
of the DRP: ”The drug is taken for too long (dependency)”, 
the pharmacy staff counselled on self-medication and self-
care and provided written information. 
 
Discussion 
DRPs were identified for 21.0 % of OTC-customers and for 
20.0 % of all OTC requests. On average, a customer with a 
DRP had 1.5 DRP. In the German study, DRPs were identified 
in 17.6 % of all self-medication requests and in 18.3 % of all 
patients
17. In both countries there was only a small difference 
in the result per customer and the result per drug request. 
The frequency of DRPs is slightly higher in Denmark than in 
Germany, but the overall level was similar. Both studies 
underline that self-medication is frequently associated with 
risks.   Original Research  PHARMACY PRACTICE 
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The most frequent DRPs were: “The choice of self-medication 
is not appropriate/optimal for the condition” in 44.8 % of the 
DRPs; “Too little of the drug is being taken” in 17.0 %; ”The 
drug is taken for too long (dependency)” in 15.0 %, and 
“Adverse drug events” in 13.8 %. We see similarities to the 
German study where the most frequent DRP is “Self-
medication inappropriate” (29.7 %), “Requested drug 
inappropriate” (20.5 %) and “Intended duration of drug use 
too high” (17.1 %)
17. The figures are, however, not direct 
comparable as the Danish figures are % per customer and the 
German are % per request. 
 
The most frequent symptom was pain (57 % of all customers). 
The most frequent DRPs in this group were the same 
problems as mentioned above, and this result is very similar 
to the German study where pain, and respiratory and 
gastrointestinal complaints were the most frequent 
indications
17. The second most frequent symptom was 
allergy/hay fever. This is probably due to seasonal variations 
as our data were collected in June/July, a time of the year 
with much pollen. The German study was performed in 
August and September, and here allergy was ranked 12 on 
the list of distribution of DRPs by indication. The phrasing of 
the question of the Danish questionnaire was, however, 
modified in comparison to the German due to the 
malfunctioning of some of the questions in the German 
questionnaire
17. Direct comparison is, therefore, not possible 
on this issue.  
 
For customers with DRPs, 78 % of the DRPs were partly or 
completely solved, and 73 % of these were solved without 
involving a GP. The German study reported a higher level of 
problem solving.  DRPs were solved for 44.9 % or partly 
solved for 45.3 % of all DRPs
17. The Danish pharmacy staff 
reported that this question was difficult as they lacked factual 
information and in many cases the response was an 
estimation of a future effect. This is to be expected as we are 
dealing with a question concerning the future. Data are self-
reported, which gives a potential risk of bias, especially as 
regards questions involving estimation. This is in particular an 
issue with respect to pharmacy staff’s estimating whether the 
problem was solved, partly solved or not solved.  
 
The study design implied that the pharmacies should register 
100 consecutive customers; all requests for OTC-medicines 
should be registered (up to a maximum of three 
requests/customer) for these 100 customers. This design was 
chosen to avoid selection bias and ensure that the study 
population was representative of the general population. Of 
the study population, 64 % were female, 65 % were between 
21 and 64 years old, and 20 % were 65 or older. 
The statistics from the Association of Danish Pharmacies 
report that 79 % of all customers are prescription customers 
and of these 56 % are female and 48 % are between 20 and 
64 years old, 45 % are 65 or older. Comparing the study 
population of OTC-customers to pharmacy customers in 
general, reveals that the survey included younger people and 
more female. The data from the Association of Danish 
Pharmacies, however, does not include information on 
gender and age for OTC customers (21 % of all customers) 
hence no direct comparison is possible
29. 
 
Both the Danish and the German study confirm UK studies 
finding that OTC medicines should be treated with the same 
care as prescribed medicines
22. Pharmaceutical counselling is 
an important instrument for assuring treatment 
appropriateness and safety of OTC drugs, and it is 
recommended to introduce quality assurance for 
counselling
9.  
 
A recent Swedish survey on the sale of non-prescription 
medicines inside and outside a pharmacy concludes that in 
many cases, counselling is incomplete or directly incorrect 
from both places. Ignorance about the differences between 
different types of pain killers can lead to the wrong choice of 
drugs and to an increased risk of adverse effects. There are 
gaps in the knowledge of what an employee outside 
pharmacies may say or not say to a client about a drug. The 
editor recommends that outlets which sell medicine 
continuously educate their staff in what they can say and not 
say about a drug, and when to refer to a pharmacist
30.  
Our study does not describe the situation in outlets outside 
community pharmacies, and hence it may not be 
representative for the total frequency of DRPs in relation to 
OTC medicines in Denmark. Based on the Swedish findings it 
can be anticipated that there is less help for resolving DRPs 
outside the pharmacies. 
 
 The results document the importance of having focus on 
counselling in relation to OTC medicines. It is recommended 
in the Swedish report that other medicine outlets than 
pharmacies refer customers to a pharmacy or a general 
practitioner when a medical condition is presented to them. 
This underlines that pharmacy is in a unique position for this 
counselling and should make use of that for the sake of 
patient safety. 
 
Conclusions 
DRPs were identified for 21 % of the pharmacy customers 
presenting a symptom or asking for an OTC medicine. The 
frequency of DRPs was slightly higher in Denmark than in 
Germany (18 %), but the overall level was similar. Both Original Research  PHARMACY PRACTICE 
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studies document that self-medication is frequently 
associated with risks.   
 
It is not possible to determine the magnitude of the safety 
risk involved. Based on the most frequent categories of DRPs, 
there were risks of insufficient effect, unintended effects and, 
to a lesser extent, inappropriate self-medication. 
Both the Danish and the German study documented that 
community pharmacies are in a unique position for 
counselling on self-medication. Pharmacies should focus on 
this role for the sake of patient safety. 
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Table 1: Basic study data: Numbers and percentages of total number of customers 
 
Study period  June - July 2011 
Community pharmacies,   39 
Customers,   3,868 
Documented OTC requests  4,324 
Documented DRPs  1,239 
OTC requests with a DRP, n=842   19.7 % 
Customers with a DRP, n=813   21.0 % 
Customers, n     
with one DRP  488 
with two DRPs  259 
with three DRPs  40 
with four DRPs  21 
with five DRPs  2 
with six DRPs  3 
Customer’s gender, n (%)    
Female, n=2409  64.0 % 
Male, n=1356  36.0 % 
Estimated age group (years) of customers, n (%)   
0-15, n=398  10.4 % 
16-20, n=187  4.9 % 
21-40, n=1,145  29.8 % 
41-65, n=1,353  35.2 % 
> 65, n=759  19.8 % 
Symptom presentation, n=777   20.6 % 
OTC medicine request, n=3,451   91.3 % 
First-time request, n=1,011  26.8 % 
Repeat request, n=3,217  85.2 % 
Result of intervention, n (%)   
DRP solved, n=343   45.6 % 
DRP partially solved, n=244  32.4 % 
DRP do not know if the problem is solved, n=81  10.8 % 
DRP not solved, n=84  11.2 % 
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Table 2: Types of DRPs registered for customers with DRPs and for all customers 
 
 
 
DRP 
Number 
of DRPs 
registered 
% of 
customers 
with DRP 
n=813 
% of all 
customers 
n=3,868 
Choice of self-medication is not appropriate/optimal for the condition   364  44.8   9.4 
Too little of the drug is being taken   138  17.0   3.6 
The drug is taken for too long (dependency)   122  15.0   3.2 
Adverse drug events  112  13.8   2.9 
Too much of the drug is being taken   66  8.1   1.7 
Double medication   60  7.4   1,6 
The drug is taken for too short a time   44  5.4  1.1 
Wrong use of the drug (technically)   43  5.3  1.1 
Interaction with other medicine   40  4.9  1.0 
Contraindication   35  4.3  0.9 
Other (not appropriate, problem in drug use)   215  26.4  5.6 
SUM   1,239     
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Figure 1: Counselling Interventions 
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